Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) has shared an announcement.
Sai Life Sciences Limited has allotted a total of 129,007 fully paid-up equity shares of Re 1 each following the exercise of options under its Employees Stock Option Plan 2008 and Management ESOP Plan 2018, as approved by the board on 22 February 2026. The issuance, which spans multiple exercise prices and is fully in dematerialised form, marginally expands the company’s equity base and underscores its continued use of share-based incentives to align employee and management interests with shareholder value.
The newly issued shares, listed on both BSE and NSE under existing ISIN INE570L01029, reflect the ongoing implementation of SEBI-compliant stock-based benefit schemes, with detailed disclosures filed to meet regulatory requirements. This move signals sustained emphasis on talent retention and performance-linked rewards within Sai Life Sciences, while resulting in limited dilution for existing shareholders given the relatively small size of the allotment.
More about SAI Life Sciences Ltd.
Sai Life Sciences Limited is an India-based company listed on BSE and NSE that operates in the broader life sciences and pharmaceutical sector. The company issues equity shares with a face value of Re 1 and uses employee stock option plans as part of its compensation and retention strategy for staff and management.
Average Trading Volume: 24,302
Technical Sentiment Signal: Strong Buy
Current Market Cap: 199B INR
Find detailed analytics on SAILIFE stock on TipRanks’ Stock Analysis page.